In vitro Opposition binding studies verified that MAM-2201 and AM-2201 possess nanomolar affinity for both equally CD-1 murine and human CB1 and CB2 receptors, with desire for your CB1 receptor. In agreement Using the in vitro binding details, in vivo reports confirmed that MAM-2201 induces Visible, acoustic, and tactile impairments https://roberta838kzo1.wikicarrier.com/user